
Sustainability: How Realistic are Pharma’s De-Carbonisation Targets?
Pharma sustainability targets will only be met if there is real change, says Dragana Cvijanovic, Business Director, Processability & Sustainability for BD.

Pharma sustainability targets will only be met if there is real change, says Dragana Cvijanovic, Business Director, Processability & Sustainability for BD.

What is the best way to drive the sustainability agenda of your company? “Get started,” says Chris Shanahan, VP Global Sustainability Supply Chain at Thermo Fisher Scientific

David Blanco, Industrial Business Development & CDMO Director, explains the services that they offers to customers.

AstraZeneca has recently announced a partnership with Vanguard Renewables to supply renewable natural gas (RNG) to its U.S. manufacturing facilities. This move is part of AstraZeneca’s commitment to reducing its environmental impact by using organic-produced fuel in all of its

“Process chemistry alone is no longer the whole story—it needs to be connected with engineering solutions, digital tools, and data utilization” Stefan Randl, Chief Scientific Officer at Siegfried, joined the Swiss-based CDMO in January 2025 after 16 years at Evonik,

“Environmental Sustainability can be a substantial differentiator for CDMOs” Jürgen Wieland, Development Environmental Sustainability Lead at Novartis, is committed to mitigating the harmful health implications of emissions caused by the global healthcare sector. With healthcare responsible for 4-5% of global